Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FR07U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,748
Award facts
- Contract value 100% obligated
- $25,748.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp (now operating under parent company Cencora, Inc.) received a $25,748.25 firm fixed-price delivery order from the Defense Logistics Agency on January 8, 2026, for Trelegy Ellipta 100-62.5-25 inhalation powder in a 60-dose configuration. This is a non-set-aside competitive award with an ultimate completion date of January 9, 2026, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under a larger Indefinite Delivery Contract vehicle.
This award falls under Amerisourcebergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. Trelegy Ellipta is a combination inhaler used in respiratory disease management, consistent with Amerisourcebergen's established role as a critical supplier of brand-name and generic pharmaceuticals, specialty medications, and medical supplies to support Defense Health Agency operations and other federal healthcare systems. The company's competitive award reflects its demonstrated capability to meet federal procurement requirements for pharmaceutical products across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FR07U?
SPE2DR26FR07U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FR07U worth?
The government has obligated $25,748 on SPE2DR26FR07U.
Is contract SPE2DR26FR07U an order under another contract?
Yes. SPE2DR26FR07U is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FR07U competed?
The extent of competition for SPE2DR26FR07U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award